Neuroferritinopathy: a new inborn error of iron metabolism - PubMed (original) (raw)
Neuroferritinopathy: a new inborn error of iron metabolism
Michael J Keogh et al. Neurogenetics. 2012 Feb.
Abstract
Neuroferritinopathy is an autosomal dominant progressive movement disorder which occurs due to mutations in the ferritin light chain gene (FTL1). It presents in mid-adult life and is the only autosomal dominant disease in a group of conditions termed neurodegeneration with brain iron accumulation (NBIA). We performed brain MRI scans on 12 asymptomatic descendants of known mutation carriers. All three harbouring the pathogenic c.460InsA mutation showed iron deposition; these findings show pathological iron accumulation begins in early childhood which is of major importance in understanding and developing treatment for NBIA.
Figures
Fig. 1
Transaxial T2*-weighted gradient echo images at the level of the a midbrain, b basal ganglia, c thalami and d motor cortex. Gene-positive subject (subject A) from the 6–16-year-old group. Signal hypointensity is seen in the substantia nigra (a, b) and globus pallidus (c)
Fig. 2
Subject B (17–25-year-old group). T2* signal hypointensity in the substantia nigra (a, arrow), red nucleus (a, arrowhead), globus pallidus (b, c) and thalami (c, arrow). There is faint hypointensity involving the motor strip (d, arrow)
Fig. 3
Subject C (27–36-year-old group). Substantia nigra and red nucleus (a), globus pallidus and thalamus (b, c) and motor cortex (d) T2* signal hypointensity. The thalamic hypointensity in particular is more prominent than in subjects A and B
Similar articles
- A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits.
Maccarinelli F, Pagani A, Cozzi A, Codazzi F, Di Giacomo G, Capoccia S, Rapino S, Finazzi D, Politi LS, Cirulli F, Giorgio M, Cremona O, Grohovaz F, Levi S. Maccarinelli F, et al. Neurobiol Dis. 2015 Sep;81:119-33. doi: 10.1016/j.nbd.2014.10.023. Epub 2014 Nov 4. Neurobiol Dis. 2015. PMID: 25447222 Free PMC article. - Pathogenic mechanism and modeling of neuroferritinopathy.
Cozzi A, Santambrogio P, Ripamonti M, Rovida E, Levi S. Cozzi A, et al. Cell Mol Life Sci. 2021 Apr;78(7):3355-3367. doi: 10.1007/s00018-020-03747-w. Epub 2021 Jan 13. Cell Mol Life Sci. 2021. PMID: 33439270 Free PMC article. Review. - A novel FTL mutation responsible for neuroferritinopathy with asymmetric clinical features and brain anomalies.
Moutton S, Fergelot P, Trocello JM, Plante-Bordeneuve V, Houcinat N, Wenisch E, Larue V, Brugières P, Clot F, Lacombe D, Arveiler B, Goizet C. Moutton S, et al. Parkinsonism Relat Disord. 2014 Aug;20(8):935-7. doi: 10.1016/j.parkreldis.2014.04.026. Epub 2014 May 9. Parkinsonism Relat Disord. 2014. PMID: 24907184 No abstract available. - 7T MRI detects widespread brain iron deposition in neuroferritinopathy.
Murley AG, Rua C, Biggs H, Rodgers CT, Matys T, van den Ameele J, Horvath R, Chinnery PF. Murley AG, et al. Ann Clin Transl Neurol. 2024 May;11(5):1359-1364. doi: 10.1002/acn3.52053. Epub 2024 Apr 1. Ann Clin Transl Neurol. 2024. PMID: 38561955 Free PMC article. - Neuroferritinopathy.
Lehn A, Boyle R, Brown H, Airey C, Mellick G. Lehn A, et al. Parkinsonism Relat Disord. 2012 Sep;18(8):909-15. doi: 10.1016/j.parkreldis.2012.06.021. Epub 2012 Jul 17. Parkinsonism Relat Disord. 2012. PMID: 22818529 Review.
Cited by
- Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).
Schneider SA, Bhatia KP. Schneider SA, et al. J Neural Transm (Vienna). 2013 Apr;120(4):695-703. doi: 10.1007/s00702-012-0922-8. Epub 2012 Dec 2. J Neural Transm (Vienna). 2013. PMID: 23212724 Review. - Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN).
Gore E, Appleby BS, Cohen ML, DeBrosse SD, Leverenz JB, Miller BL, Siedlak SL, Zhu X, Lerner AJ. Gore E, et al. Neurocase. 2016 Oct;22(5):476-483. doi: 10.1080/13554794.2016.1247458. Epub 2016 Nov 1. Neurocase. 2016. PMID: 27801611 Free PMC article. - iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease.
Arber C, Angelova PR, Wiethoff S, Tsuchiya Y, Mazzacuva F, Preza E, Bhatia KP, Mills K, Gout I, Abramov AY, Hardy J, Duce JA, Houlden H, Wray S. Arber C, et al. PLoS One. 2017 Sep 1;12(9):e0184104. doi: 10.1371/journal.pone.0184104. eCollection 2017. PLoS One. 2017. PMID: 28863176 Free PMC article. - Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach.
Tonduti D, Chiapparini L, Moroni I, Ardissone A, Zorzi G, Zibordi F, Raspante S, Panteghini C, Garavaglia B, Nardocci N. Tonduti D, et al. Curr Neurol Neurosci Rep. 2016 Jun;16(6):54. doi: 10.1007/s11910-016-0656-3. Curr Neurol Neurosci Rep. 2016. PMID: 27074771 Review. - Voxel-based analysis in neuroferritinopathy expands the phenotype and determines radiological correlates of disease severity.
Keogh MJ, Aribisala BS, He J, Tulip E, Butteriss D, Morris C, Gorman G, Horvath R, Chinnery PF, Blamire AM. Keogh MJ, et al. J Neurol. 2015 Oct;262(10):2232-40. doi: 10.1007/s00415-015-7832-2. Epub 2015 Jul 4. J Neurol. 2015. PMID: 26142024 Free PMC article.
References
- Curtis AR, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28(4):350–354. - PubMed
- Vidal R, et al. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol. 2004;63(4):363–380. - PubMed
- Mancuso M, et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol. 2005;64(4):280–294. - PubMed
- Ohta E, et al. Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene. Neurology. 2008;70(16 Pt 2):1493–1494. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
- WT_/Wellcome Trust/United Kingdom
- NEWBRC-2012-1/DH_/Department of Health/United Kingdom
- 071095/WT_/Wellcome Trust/United Kingdom
- 084980/WT_/Wellcome Trust/United Kingdom
- 101876/WT_/Wellcome Trust/United Kingdom
- 096919/WT_/Wellcome Trust/United Kingdom
- MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous